Details

Autor(en) / Beteiligte

• Barylnik, Y.
• Kolesnichenko, E.
• Abrosimova, Y.
• Pakhomova, S.
• Samoylova, D.
• Filippova, N.
• Bachilo, E.
• Antonova, A.
• Sizov, S.
• Ledvanova, T.
• Kuryshev, V.

Titel

Clinical and genetic predictors of the severity and activity of paranoid schizophrenia

Ist Teil von

• European psychiatry, 2017-04, Vol.41 (S1), p.S803-S803

Ort / Verlag

Elsevier Masson SAS

Erscheinungsjahr

2017

Beschreibungen/Notizen

• Clinical symptoms, course and outcomes of paranoid schizophrenia are polymorphic. Reliable predictors of severity and activity of schizophrenic process could provide clinicians important prognostic information for adequate and timely implementation of therapeutic and rehabilitative measures. Overall, 206 patients with paranoid schizophrenia were examined. Clinical predictors were collected from hospital records and interviews. BDNF gene Val66Met polymorphism (rs6265 G>A), DRD2 gene C939T polymorphism (rs6275C>T) and 5-HTR2A gene T102C polymorphism (rs6313 T>C) were studied as potential markers of prognosis for paranoid schizophrenia. Results of research testify that the DRD2 gene C939T polymorphism and 5-HTR2A gene T102C polymorphism cannot be used as predictors of the severity and activity of paranoid schizophrenia. The MetMet genotype of BDNF gene Val66Met polymorphism can be used as marker of favorable prognosis for paranoid schizophrenia. Schizoid, epileptoid, psychasthenic and conformal accentuation of personality in the premorbid, early onset of psychosis, paranoid and hallucinatory-paranoid variants of onset predicted more expressed severity of paranoid schizophrenia. These prognostic factors can be taken into account in clinical practice.